Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients

American Journal of Kidney Diseases

Volumn 60, Issue 1, 2012, Pages 112-120

  Kucirka, Lauren M ^a   Peters, Thomas G ^b   Segev, Dorry L ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

competing risks; Hepatitis C; kidney transplant; liver transplant

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; KIDNEY GRAFT; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; COMORBIDITY; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; TISSUE DONORS; WAITING LISTS;

EID: 84862607089     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.03.015     Document Type: Article

References (14)

1. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, et al. Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol. 2007;18(5):1584-1593.
2. Wang SM, Liu JH, Chou CY, Huang CC, Shih CM, Chen W. Mortality in hepatitis C-positive patients treated with peritoneal dialysis. Perit Dial Int. 2008;28(2):183-187.
3. Butt AA, Skanderson M, McGinnis KA, et al. Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis. J Viral Hepat. 2007;14(10):688-696.
4. Fabrizi F, Messa P, Martin P. Current status of renal transplantation from HCV-positive donors. Int J Artif Organs. 2009;32(5):251-261.
5. Kucirka LM, Singer AL, Ros RL, Montgomery RA, Dagher NN, Segev DL. Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients. Am J Transplant. 2010;10(5):1238-1246.
6. Bucci JR, Lentine KL, Agodoa LY, Peters TG, Schnitzler MA, Abbott KC. Outcomes associated with recipient and donor hepatitis C serology status after kidney transplantation in the United States: analysis of the USRDS/UNOS database. Clin Transpl. 2004;18(1):51-61.
7. United Network for Organ Sharing. Standard Analysis Files. 1995-2009. Accessed September 15, 2009.
8. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
9. Abbott KC, Lentine KL, Bucci JR, Agodoa LY, Peters TG, Schnitzler MA. The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant. 2004;4(12):2032-2037.
10. Batty DS Jr, Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant. 2001;1(2):179-184.
11. Bloom RD, Sayer G, Fa K, Constantinescu S, Abt P, Reddy KR. Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant. 2005;5(1):139-144.
12. Lonardo A, Adinolfi LE, Petta S, Craxi A, Loria P. Hepatitis C and diabetes: the inevitable coincidence? Expert Rev Anti Infect Ther. 2009;7(3):293-308.
13. Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation - clinically appropriate or due to underuse or overuse? N Engl J Med. 2000;343(21):1532, 1537-1544.
14. Mandal AK, Kraus ES, Samaniego M, et al. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors. Clin Transplant. 2000;14(4, pt 2):391-396.